McLaren Cancer Institute-Macomb
Mount Clemens, Michigan, United States
Cancer treatment center in Mount Clemens, Michigan
1080 Harrington St, Mt Clemens, MI 48043
About McLaren Cancer Institute-Macomb
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at McLaren Cancer Institute-Macomb
During the past decade, McLaren Cancer Institute-Macomb conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 20 clinical trials were completed, i.e. on
average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
2005-06-01
2009-08-01
Completed
64
S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
2005-08-01
2009-08-01
Completed
112
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
2006-05-01
2010-04-01
Completed
48
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "McLaren Cancer Institute-Macomb" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "SWOG Cancer Research Network" with 15 trials
sponsored, "NRG Oncology" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 10 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Macomb"
#1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at McLaren Cancer Institute-Macomb
According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Macomb" are
"Breast Cancer" (6 trials), "Lung Cancer" (5 trials), "Invasive Breast Carcinoma" (4 trials), "Prostate Adenocarcinoma" (4 trials) and "Recurrent Breast Carcinoma" (4 trials). Many other conditions were trialed in "McLaren Cancer Institute-Macomb" in a lesser frequency.
Clinical Trials Intervention Types at McLaren Cancer Institute-Macomb
Most popular intervention types in "McLaren Cancer Institute-Macomb" are "Drug" (57 trials), "Other" (42 trials), "Radiation" (33 trials), "Biological" (28 trials) and "Procedure" (14 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (24 trials), "Laboratory Biomarker Analysis" (20 trials), "Questionnaire Administration" (13 trials), "Radiation Therapy" (10 trials) and "Cisplatin" (9 trials). Other intervention names were less common.
Clinical Trials Genders at McLaren Cancer Institute-Macomb
The vast majority of trials in "McLaren Cancer Institute-Macomb" are
54 trials for "All" genders, 12 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at McLaren Cancer Institute-Macomb
Currently, there are NaN active trials in "McLaren Cancer Institute-Macomb".
undefined are not yet recruiting,
15 are recruiting,
39 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in McLaren Cancer Institute-Macomb,
3 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in McLaren Cancer Institute-Macomb, 3 "Phase 1"
clinical trials were conducted, 29 "Phase 2" clinical
trials and 47 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".